Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial.

Reza AhmadiSoofia SalariMohammad Davood SharifiHamidreza ReihaniMohammad Bagher RostamianiMorteza BehmadiZhila TaherzadehSaeed EslamiSeyed Mahdi RezayatMahmoud Reza JaafariSepideh Elyasi

Published in: Food science & nutrition (2021)

Oral nanoformulation of curcumin can significantly improve recovery time in patients with mild to moderate COVID-19 in outpatient setting. Further studies with larger sample size are recommended.

Keyphrases

coronavirus disease
sars cov
clinical trial
double blind
placebo controlled
phase ii
study protocol
phase iii
drug delivery
open label
radiation therapy